Schedule 13D ownership disclosure

APREA THERAPEUTICS INC

Security class unavailable · CUSIP: 03836J102

Event date: 2019-10-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,418,548
Percent of class
11.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-054703
Form type
SC 13D
Filer
5AM Ventures IV, L.P.
CIK
CIK 1589315
Filed
Oct 17, 2019
Reporting period
Oct 07, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub